YCBD CIK: 1644903

cbdMD, Inc.

  • United States
  • Healthcare
  • Pharma
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
30.0
FY22:
22.3
FY23:
15.0
FY24:
12.0
FY25:
12.0
(positive)
Change from FY21 to FY25
millions USD
FY21:
−19.6
FY22:
−78.3
FY23:
−22.5
FY24:
−2.17
FY25:
−1.04
(positive)
Change from FY21 to FY25
millions USD
FY21:
−17.3
FY22:
–
FY23:
–
FY24:
−1.57
FY25:
−0.37
(positive)
Change from FY21 to FY25
millions USD
FY21:
−24.3
FY22:
−70.1
FY23:
−22.9
FY24:
−3.70
FY25:
−2.04
(positive)
Change from FY21 to FY25
millions USD
FY21:
−23.4
FY22:
−70.1
FY23:
−22.9
FY24:
−3.70
FY25:
−2.04

All amounts in millions USD Data sources:SEC EDGARTwelve Data